Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.7 (
plasmin
)
9,023
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The ability of human plasma and purified human
plasmin
and plasminogen to hydrolyze a new synthetic substrate, H-D-valine-leucine-lysine-
5-aminoisophthalic acid
, dimethyl ester, ditrifluoroacetate, was studied. Contrary to published data, we found this substrate was only minimally hydrolyzed by
plasmin
or urokinase-treated plasminogen or plasma. Plasminogen-free bovine fibrinogen was readily degraded by
plasmin
and urokinase-activated plasminogen. However, in the presence of streptokinase, the synthetic substrate was highly sensitive to human plasma and purified
plasmin
and plasminogen. Apparently, the substrate is specific for streptokinase-
plasmin
and streptokinase-plasminogen activators, not for
plasmin
.
...
PMID:H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin. 645 54